Top Story

Stem cell-derived islet replacement for type 1 diabetes implanted in first patient

October 30, 2014

The experimental encapsulated cell therapy product candidate called VC-01, designed to treat type 1 diabetes, was successfully implanted into the first patient, according to statements from developer ViaCyte and its funding partner, the Juvenile Diabetes Research Foundation.

“In terms of potential, this is a very important first step for looking at encapsulated insertion of islets, essentially from stem cell precursors,” Steven C. Griffen, MD, vice president of translational development at JDRF, told Endocrine Today

figure Meeting News CoverageVideo

Keith C. Ferdinand, MD, highlights recent data on link between CVDs, diabetes drugs

October 30, 2014
BOSTON — At the Cardiometabolic Health Congress, Keith C. Ferdinand, MD, FACC, professor of clinical medicine at Tulane University School of Medicine in New…
FDA News

FDA approves Xigduo XR to treat adults with type 2 diabetes

October 30, 2014
The FDA approved a formulation combining two antihyperglycemic agents in a once-daily extended-release tablet to treat adults with type 2 diabetes, according to a…
In the Journals

Strict glycemic targets should be 'abandoned' for patients undergoing cardiac surgery

October 29, 2014
Patients undergoing cardiac surgery showed similar mean perioperative glucose values but improved hypoglycemia rates after recommended…
CME
figure

Dialogues in Diabetes: An eJournal Series on Incretin Therapies

This eJournal series consists of expert commentary and key highlights from the Editorial Board of the CME publication…
More »
Meeting News Coverage Video
figure

Keith C. Ferdinand, MD, highlights recent data on link between CVDs, diabetes drugs

October 30, 2014
BOSTON — At the Cardiometabolic Health Congress, Keith C. Ferdinand, MD, FACC, professor of clinical medicine at…
More »
CME
figure

Dialogues in Diabetes: Volume 3, Number 4

Recent advances in incretin-based therapies have targeted reducing cardiovascular risk in patients with type 2 diabetes…
More »

Filter By:

Stem cell-derived islet replacement for type 1 diabetes implanted in first patient

October 30, 2014
The experimental encapsulated cell therapy product candidate called VC-01, designed to treat type 1 diabetes, was successfully…
figure Meeting News Coverage Video

Keith C. Ferdinand, MD, highlights recent data on link between CVDs, diabetes drugs

October 30, 2014
BOSTON — At the Cardiometabolic Health Congress, Keith C. Ferdinand, MD, FACC, professor of clinical medicine at Tulane University School of…
FDA News

FDA approves Xigduo XR to treat adults with type 2 diabetes

October 30, 2014
The FDA approved a formulation combining two antihyperglycemic agents in a once-daily extended-release tablet to treat adults with type 2 diabetes…
In the Journals

Strict glycemic targets should be 'abandoned' for patients undergoing cardiac surgery

October 29, 2014
Patients undergoing cardiac surgery showed similar mean perioperative glucose values but improved
In the Journals

Telemonitoring reduced readmissions, costs in patients with HF

October 28, 2014
A telemonitoring program developed by Geisinger Health Plan to monitor patient weight, changes in physical condition, appetite and prescription…
In the Journals

Spinal cord stimulation may relieve painful diabetic peripheral neuropathy

October 28, 2014
Spinal cord stimulation could improve pain and sleep symptoms for patients with diabetes and peripheral neuropathy previously unresponsive to…
figure In the Journals

Type 1 diabetes rate increased among non-Hispanic white youth

October 28, 2014
From 2002 to 2009, the rate at which non-Hispanic white youth in the United States were diagnosed with type 1 diabetes increased significantly in…
figure In the Journals

First-line metformin treatment decreased need for subsequent treatment in diabetes

October 27, 2014
More than 40% of patients with diabetes do not start out their glucose-lowering regimen with metformin despite recommended guidelines, according to…

Clinical trial results for oral insulin show promise

October 25, 2014
Oramed Pharmaceuticals Inc. recently announced positive clinical results from its phase 2a clinical trial of ORMD-0801, oral insulin capsules, to…

Novo Nordisk diabetes program receives certification

October 25, 2014
Novo Nordisk recently received disease management certification in program design from the National Committee for Quality Assurance for its diabetes…
More Headlines »